Skip to main content
Clinical Trials/NCT00626977
NCT00626977
Completed
Not Applicable

Labor Analgesia With Ropivacaine Added to Clonidine. A Randomized Clinical Trial

UPECLIN HC FM Botucatu Unesp1 site in 1 country32 target enrollmentMay 2000

Overview

Phase
Not Applicable
Intervention
ropivacaine
Conditions
Labor Pain
Sponsor
UPECLIN HC FM Botucatu Unesp
Enrollment
32
Locations
1
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aim of the present study was to examine, for pain relief during labor, the efficacy of two pharmacological approaches - the 0.125% ropivacaine alone and the 0.0625% ropivacaine added to 75 ug clonidine, both by epidural administration. The effect of the drugs on mother and newborn was also determined.

Registry
clinicaltrials.gov
Start Date
May 2000
End Date
December 2001
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
UPECLIN HC FM Botucatu Unesp
Responsible Party
Principal Investigator
Principal Investigator

Yara Marcondes Machado Castiglia

MD PhD

UPECLIN HC FM Botucatu Unesp

Eligibility Criteria

Inclusion Criteria

  • Singleton healthy
  • Full-term pregnancy
  • American Society of Anesthesiologists physical status I or II

Exclusion Criteria

  • Patients who had received opioids
  • History of hypersensitivity to local anesthetic or to clonidine
  • Fetus showed signs of possible intrauterine suffering
  • Fetus showed signs of possible neurological deficit

Arms & Interventions

R

R group:15 mL of 0.125% ropivacaine (18.75 mg)

Intervention: ropivacaine

RC

RC group:0.0625% ropivacaine (9.375 mg) plus 75 ug clonidine

Intervention: ropivacaine and clonidine

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials